新型毒品
Redesigner drugs.
作者信息
Dove Alan
出版信息
Nat Biotechnol. 2004 Aug;22(8):953-7. doi: 10.1038/nbt0804-953.
PMID:15286643
Abstract
Drug development is a risky business, and the final product can have serious, sometimes deadly flaws. But by focusing on fixing those flaws, companies are catapulting themselves to profitability.
摘要
药物研发是一项风险极高的业务，最终产品可能存在严重的、有时甚至是致命的缺陷。但通过专注于修复这些缺陷，企业正在迅速实现盈利。
Zotero 插件